Supernus Pharmaceuticals, Inc. (SUPN)
55.09
+0.36
(+0.66%)
USD |
NASDAQ |
Mar 02, 16:00
55.21
+0.12
(+0.22%)
After-Hours: 20:00
Supernus Pharmaceuticals Accounts Payable (Quarterly) : 107.80M for Dec. 31, 2025
Accounts Payable (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Accounts Payable (Quarterly) Benchmarks
| Biogen, Inc. | 432.00M |
| BridgeBio Pharma, Inc. | 36.23M |
| Corcept Therapeutics, Inc. | 40.44M |
| Catalyst Pharmaceuticals, Inc. | 11.20M |
| Cytokinetics, Inc. | 22.34M |